MRA Advisory Group Boosts Stake in Doximity, Inc. $DOCS

Key Points

• MRA Advisory Group has increased its stake in Doximity, Inc. by 57.9%, owning 13,733 shares valued at approximately $842,000.
• Doximity reported $0.36 EPS for the last quarter, exceeding analysts' expectations, with a net margin of 36.60% and revenue growth of 15.2% year-over-year.
• Analysts have varying opinions on Doximity, with price targets ranging from $55.00 to $80.00 and an average rating of "Moderate Buy."

MRA Advisory Group boosted its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 57.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,733 shares of the company's stock after acquiring an additional 5,038 shares during the quarter. MRA Advisory Group's holdings in Doximity were worth $842,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Ballentine Partners LLC bought a new stake in Doximity during the first quarter worth approximately $201,000. Wealth Enhancement Advisory Services LLC increased its stake in Doximity by 196.6% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 13,570 shares of the company's stock worth $787,000 after acquiring an additional 8,995 shares during the last quarter. Range Financial Group LLC bought a new stake in Doximity during the first quarter worth approximately $916,000. Bank of Nova Scotia bought a new stake in Doximity during the first quarter worth approximately $651,000. Finally, New York State Teachers Retirement System increased its stake in Doximity by 10.9% during the first quarter. New York State Teachers Retirement System now owns 113,145 shares of the company's stock worth $6,566,000 after acquiring an additional 11,078 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Doximity Trading Down 0.5%

Shares of NASDAQ DOCS traded down $0.39 during trading hours on Friday, reaching $73.21. The stock had a trading volume of 474,856 shares, compared to its average volume of 2,192,756. The firm has a market cap of $13.71 billion, a price-to-earnings ratio of 73.30, a P/E/G ratio of 4.10 and a beta of 1.37. The business's fifty day moving average price is $64.51 and its two-hundred day moving average price is $59.99. Doximity, Inc. has a 52-week low of $40.15 and a 52-week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm's revenue for the quarter was up 15.2% compared to the same quarter last year. During the same period last year, the business earned $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities research analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

DOCS has been the topic of several analyst reports. Canaccord Genuity Group boosted their price objective on Doximity from $59.00 to $67.00 and gave the stock a "hold" rating in a research note on Thursday. BTIG Research raised Doximity from a "neutral" rating to a "buy" rating and set a $80.00 target price on the stock in a research note on Monday, June 2nd. Zacks Research cut Doximity from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Piper Sandler upped their target price on Doximity from $65.00 to $69.00 and gave the company an "overweight" rating in a research note on Monday, August 11th. Finally, Truist Financial upped their target price on Doximity from $52.00 to $61.00 and gave the company a "hold" rating in a research note on Thursday, July 17th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $67.42.

Insider Activity at Doximity

In related news, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the sale, the director owned 16,618 shares in the company, valued at approximately $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy S. Cabral sold 10,000 shares of the business's stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the sale, the director owned 6,360 shares of the company's stock, valued at $381,600. The trade was a 61.12% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 37,000 shares of company stock worth $2,281,880. Company insiders own 31.30% of the company's stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.